Multiple Myeloma

Nebraska Medicine is known nationally for being a leading multiple myeloma treatment center.

Specializing in state of the art chemotherapy and immunotherapy, blood and marrow transplants and surgical options for comprehensive multiple myeloma treatment.

Since performing its first bone marrow transplant in 1983, Nebraska Medicine and its academic partner, the University of Nebraska Medical Center (UNMC), have performed more than 5,000 bone marrow transplants.

Service Options

Patient Guides

At Nebraska Medicine, You Benefit from

A Team Approach

A multidisciplinary team of multiple myeloma experts and other specialists work collaboratively to develop a comprehensive and individualized treatment plan for each patient. This includes our multiple myeloma specialists, bone marrow transplant specialists, radiation oncologists, and pain management experts.

Our team also works closely with your primary care doctor and other providers. Patients undergoing cancer treatment at Nebraska Medicine also have access to our 24/7 Infusion Center at the Peggy D. Cowdery Patient Care Center, which serves as both a treatment center and 24/7 urgent-care-type facility. A rare offering in the region.

The treatment options for multiple myeloma are changing rapidly, including four new drugs in 2015, and our specialists have experience with these new therapies and are up-to-date with the rapidly changing guidelines.

We also offer a multiple myeloma clinical trial portfolio which includes trials for newly diagnosed patients, for patients undergoing bone marrow transplant, and for patients with relapsed/refractory disease. This clinical trial portfolio offers new treatment approaches including novel drugs and cellular therapies, and positions Nebraska Medicine at the forefront of myeloma research.

Experts in the Field

The bone marrow transplant team members include Julie Vose, M.D., chief of the UNMC Division of Hematology/Oncology and the Neumann M. and Mildred E. Harris Professor, Matthew Lunning, DO, hematologist/oncologist and Muhamed Baljevic, MD.

Sarah Holstein, MD, PhD and Muhamed Baljevic, MD are myeloma specialists. Dr. Holstein has previously served as a myeloma specialist at the University of Iowa and Roswell Park Cancer Institute. She is a member of the NCCN Multiple Myeloma Panel and the Alliance Multiple Myeloma Committee. Her basic science and clinical research focuses on the development of new drugs for multiple myeloma. Dr. Baljivec received his hematology/oncology fellowship training at MD Anderson. His clinical research is focused on understanding and overcoming myeloma resistance to proteasome inhibitors.

Dr. Baljivec received his hematology/oncology fellowship training at MD Anderson. His clinical research is focused on understanding and overcoming myeloma resistance to proteasome inhibitors.

In addition, our orthopaedic doctors also specialize in treating the bone lesions that often accompany multiple myeloma.

Specialists to Treat Bone Lesions

A common symptom of multiple myeloma is bone pain, caused by bone lesions. Orthopaedic doctors who focus on just issues related to your bones assist with properly diagnosing and treating these.

We Help Write the Guidelines

Not only is Nebraska Medicine a leader in multiple myeloma, but our doctors are constantly evaluating and updating the guidelines for myeloma care and treatment.

The Fred & Pamela Buffett Cancer Center at Nebraska Medicine is a National Cancer Institute (NCI) Designated Cancer Center, one of 69 NCI Designated Cancer Centers in the country. This an alliance of some of the country’s leading cancer centers that collaborate to produce standard evidence-based guidelines for cancer treatment.

Pioneering New Treatments

Nebraska Medicine's myeloma program is extremely active in clinical research and clinical trials, providing you with access to the most up-to-date and revolutionary treatments. We are a primary member of the Alliance for Clinical Trials in Oncology, an NCI sponsored cooperative group and a core center for the Bone Marrow Transplant Clinical Trials Network (BMT/CTN).

Nebraska Medicine is also part of the National Institutes of Health/National Cancer Institute Bone Marrow Transplant Clinical Trials Network – a consortium of approximately 20 transplant centers across the country that collaborate on clinical trials in order to derive data from a larger population of patients and to allow for greater sharing of information between centers. Through this network, doctors can study and refine their techniques to diagnose, treat and follow patients, providing them with the most optimal care.

Addressing Your Personal Care Needs

Addressing a patient’s physical, educational, emotional and spiritual needs are important aspects of providing a more complete and holistic approach to care. A host of amenities and supportive services are available to help meet these needs. This includes personal care services such as wigs, wig fittings, prosthetic and bra fittings, yoga, massage therapy, skin care and make-up lessons specifically geared for people with or recovering from cancer are also provided in a private setting.

Cancer Support Services

Finding out that you have cancer can be a very emotional and difficult time. You will likely have many questions and issues to work through. We will be with you every step of the way. Nebraska Medicine offers a host of cancer support services to help you with your physical, emotional, educational and financial needs.

We're Here for you Long After Your Treatment

Our Survivorship Clinic is designed to help you deal with the emotional and physical challenges cancer can leave behind such as fear of recurrence, physical and medical long-term side effects and helping you return to a normal life again. It will also help you transition back into the care of your primary care physician.